Cite
HARVARD Citation
Rein‐Hedin, E. et al. (2021). First‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers. Clinical pharmacology in drug development. 10 (12), pp. 1485-1494. [Online].